Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection
Autore:
Ueno, H; Okada, S; Okusaka, T; Ikeda, M; Tanaka, N; Sakamoto, M; Yoshimori, M;
Indirizzi:
Natl Canc Ctr Hosp, Dept Internal Med, Chuo Ku, Tokyo 1040045, Japan Natl Canc Ctr Hosp Tokyo Japan 1040045 ed, Chuo Ku, Tokyo 1040045, Japan Natl Canc Ctr, Res Inst, Div Pathol, Tokyo 104, Japan Natl Canc Ctr Tokyo Japan 104 tr, Res Inst, Div Pathol, Tokyo 104, Japan
Titolo Testata:
HEPATO-GASTROENTEROLOGY
fascicolo: 41, volume: 48, anno: 2001,
pagine: 1430 - 1434
SICI:
0172-6390(200109/10)48:41<1430:POHCWN>2.0.ZU;2-3
Fonte:
ISI
Lingua:
ENG
Soggetto:
CIRRHOTIC-PATIENTS; FOLLOW-UP; ANGIOGRAPHY; RECURRENCE; THERAPY; DIAGNOSIS;
Keywords:
hepatocellular carcinoma; liver; percutaneous ethanol injection; tumor stain; prognosis;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
23
Recensione:
Indirizzi per estratti:
Indirizzo: Ueno, H Natl Canc Ctr Hosp, Dept Internal Med, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan Natl Canc Ctr Hosp 5-1-1 Tsukiji Tokyo Japan 1040045 40045, Japan
Citazione:
H. Ueno et al., "Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection", HEP-GASTRO, 48(41), 2001, pp. 1430-1434

Abstract

Background/Aims. Some hepatocellular carcinoma nodules do not show tumor stain by hepatic angiography or enhanced computed tomography. The aim of this study was to clarify the prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection. Methodology: Twenty patients who had hepatocellular carcinoma with no tumor stain were treated by percutaneous ethanol injection between January 1990and June 1998. No patients had received any anticancer treatments before percutaneous ethanol injection. Recurrence-free survival, predictive factorsfor recurrence and recurrent patterns were examined. Overall survival was also examined. Results: Ten of the 20 patients showed intrahepatic recurrences in other parts of the treated lesions, although no local recurrence was observed. Median recurrence-free survival time, 1-, 3- and 5-year recurrence-free survival rates were 2.8 years, 66%, 43% and 22%, respectively. A serum alpha-fetoprotein level of 20ng/mL or less was the only factor that was significantlyassociated with prolonged recurrence-free survival. Of the 12 recurrent nodules in 10 patients, 9 occurred in different segments of the treated lesion and 8 were histopathologically con firmed to be well-differentiated hepatocellular carcinoma. Overall survival rates 1, 3, and 5 years after percutaneous ethanol injection were 100%, 82%, and 75%, respectively. Conclusions: Percutaneous ethanol injection may be useful for the treatment of hepatocellular carcinoma with no tumor stain.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/12/20 alle ore 09:28:56